RashEndZ Inc. Launches New Product To Treat Incontinent-related Skin Problems

Share Article

Eight years of development and FDA review are now coming to fruition. On Nov. 6, RashEndZ™ Inc. (http://www.RashEndZ.com) will launch REZair™, their flagship General Wellness skin-aeration product line of devices for both infant and adult patients.

“Incontinence, rashes, and bedsores affect numerous patients, so it’s incumbent on all hospitals and nursing homes to prevent these problems,” Parker says. “That is what REZairTM and DOSTTM therapy accomplishes."

After 25 years of treating severe diaper rashes in very premature babies using standard but ineffective topical-drug therapies, one neonatal ICU nurse decided to try something different.

Nurse Colleen convinced babies’ parents and doctors to let her use the respiratory oxygen source at the babies’ beds to blow oxygen onto the babies’ bottoms. While it was time-consuming, requiring her to stay overtime after 12-hour shifts, and impractical for busy nurses with multiple critically ill babies, she proved a better way was possible. Dynamic Oxygen Skin Therapy (DOSTTM) was born.

Missing, though, was technology that could fit into any diaper, connect to any standard source of gaseous respiratory oxygen, continuously deliver that oxygen to the entire baby’s diaper-covered skin, and do so even while there was a mess in the diaper. So she turned to an aerospace engineer, Nigel Parker, to get her therapy to her patients. Four years later RashEndZTM technology was patented by RashEndZ, Inc. not only for babies, but for adults and all other incontinent patients.

Eight years of development and FDA review are now coming to fruition. On Nov. 6, RashEndZ™ Inc. (http://www.RashEndZ.com) will launch REZair™, their flagship General Wellness skin-aeration product line of devices for both infant and adult patients. REZair will help hospitals, nursing homes and other health-care centers save money and improve the quality of skin health for patients who suffer from incontinence, as well as severe, even life-threatening skin problems.

Parker, founder and CEO of RashEndZ, invented the liner after years of painstaking trial-and-error attempts, but he points to “Nurse Colleen” as the true hero behind their joint mission.

“This is really about a compassionate nurse who went above and beyond the call of duty for those babies,” Parker says. “Now patients both young and old will benefit from her compassion.”

Here’s how this general-wellness product works: The skin-aeration liner is inserted inside a diaper, incontinence garment or wound dressing and is structurally designed to avoid contact with the rash or wound. REZair connects to any air/oxygen source and circulates air or oxygen on the rash. This helps keep the skin dry and speeds up skin repair and healing. The liner is disposable and a new one can be inserted in a few seconds with each diaper change.

Severe, painful diaper rash is a major issue for hospitalized infants, especially babies born prematurely who have underdeveloped skin. Adult diaper rash is a significant problem in assisted-living facilities and nursing homes, where the rashes can turn to bed sores and become infected.

“We at RashEndZ like to say that ‘Air is the New Standard of Care,’” Parker says. “For decades it’s been known that oxygen therapy is the most effective approach for maintaining healthy skin. Now this new technology provides a novel, innovative, and superior way to deliver that air or oxygen.”

The benefits to patients are clear, but there’s also value for medical facilities that need to cut operating costs even as they improve the quality of care. REZairTM helps them save money in numerous ways, such as reducing the costs for materials, nursing time, overnight stays and re-admissions. This therapy will also significantly reduce litigation risks and costs.

“Incontinence, rashes, and bedsores affect numerous patients, so it’s incumbent on all hospitals and nursing homes to prevent these problems,” Parker says. “That is what REZairTM and DOSTTM therapy accomplishes. Diaper rash treatment for babies has led to wound care for all.”

About RashEndZ Inc.
RashEndZ™ Inc. (http://www.RashEndZ.com) is the maker of REZair™, a brand of skin aeration devices for incontinent garments that maintains optimum skin health. Nigel Parker, the company’s founder and CEO, is a senior management and systems engineer with more than 30 years’ experience in aerospace, medical simulation and other high-tech industries. He is co-inventor of REZair with nurse Colleen John, BSc, RN, an NICU level III nurse who serves on the RashEndZ Clinical Advisory Board.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cathy Hayes
Visit website